0000908834-23-000047.txt : 20230526 0000908834-23-000047.hdr.sgml : 20230526 20230526131330 ACCESSION NUMBER: 0000908834-23-000047 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200211 FILED AS OF DATE: 20230526 DATE AS OF CHANGE: 20230526 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schuler Education Foundation CENTRAL INDEX KEY: 0001512977 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36385 FILM NUMBER: 23966495 BUSINESS ADDRESS: STREET 1: 100 N. FIELD DRIVE STREET 2: SUITE 360 CITY: LAKE FOREST STATE: IL ZIP: 60045 BUSINESS PHONE: 847.607.2066 MAIL ADDRESS: STREET 1: 100 N. FIELD DRIVE STREET 2: SUITE 360 CITY: LAKE FOREST STATE: IL ZIP: 60045 FORMER NAME: FORMER CONFORMED NAME: Schuler Family Foundation DATE OF NAME CHANGE: 20110214 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLASE, INC CENTRAL INDEX KEY: 0000811240 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] IRS NUMBER: 870442441 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 27042 TOWNE CENTRE DRIVE STREET 2: SUITE 270 CITY: FOOTHILL RANCH STATE: CA ZIP: 92610 BUSINESS PHONE: 949-361-1200 MAIL ADDRESS: STREET 1: 27042 TOWNE CENTRE DRIVE STREET 2: SUITE 270 CITY: FOOTHILL RANCH STATE: CA ZIP: 92610 FORMER COMPANY: FORMER CONFORMED NAME: BIOLASE TECHNOLOGY INC DATE OF NAME CHANGE: 19941117 FORMER COMPANY: FORMER CONFORMED NAME: LASER MEDICAL TECHNOLOGY INC DATE OF NAME CHANGE: 19941117 FORMER COMPANY: FORMER CONFORMED NAME: LASER ENDO TECHNIC CORP DATE OF NAME CHANGE: 19920708 4 1 form4.xml X0407 4 2020-02-11 true 0000811240 BIOLASE, INC BIOL 0001512977 Schuler Education Foundation 100 N. FIELD DRIVE SUITE 360 LAKE FOREST IL 60045 true false Common Stock 2020-02-11 4 P 0 1307931 0.61 A 10936444 D Common Stock 2020-06-08 4 S 0 1847649 0.55 D 9088795 D Common Stock 2020-06-09 4 S 0 2137559 0.54 D 6951236 D Common Stock 2020-06-10 4 S 0 1733836 0.55 D 5217400 D Common Stock 2020-07-28 4 C 0 3745000 0.4 A 8962400 D Common Stock 2020-11-24 4 S 0 71100 0.3 D 8891300 D Common Stock 2020-11-25 4 S 0 203057 0.29 D 8688243 D Common Stock 2020-11-30 4 S 0 1115000 0.3 D 7573243 D Common Stock 2020-12-04 4 S 0 1200000 0.3 D 6373243 D Common Stock 2020-12-16 4 S 0 90575 0.28 D 6282668 D Common Stock 2020-12-17 4 S 0 572671 0.28 D 5709997 D Common Stock 2020-12-18 4 S 0 187774 0.28 D 5522223 D Series F Convertible Preferred Stock 0.4 2020-07-22 4 A 0 1498 A 2020-07-22 Common Stock 3745000 1498 D Warrants 0.4 2020-07-22 4 A 0 3745000 A 2020-07-22 2025-07-22 Common Stock 3745000 3745000 D Series F Convertible Preferred Stock 0.4 2020-07-28 4 C 0 1498 D 2020-07-22 Common Stock 3745000 0 D This late filing is due to inadvertent administrative error. The sale price reported is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $0.5399 and $0.5643, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. The sale price reported is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $0.5430 and $0.5601, inclusive. The sale price reported is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $0.5485 and $0.5656, inclusive. In connection with a public offering by the Issuer, on July 22, 2020, the Reporting Person acquired (i) 1,498 shares of Series F Convertible Preferred Stock, each of which is convertible into 2,500 shares of Common Stock, for a total of up to 3,745,000 shares of Common Stock, and (ii) 3,745,000 Warrants, each of which is exercisable to purchase one share of Common Stock, for a total of up to 3,745,000 shares of Common Stock, for an aggregate purchase price of $1,500,000. Each share of Series F Convertible Preferred Stock is convertible at the Issuer's option at any time on or after July 22, 2021 or at the option of the Reporting Person at any time. On July 28, 2020, the Reporting Person converted 1,498 shares of Series F Convertible Preferred Stock into 3,745,000 shares of Common Stock. /s/ Jack W. Schuler, President 2023-05-26